Kiwa Bio-tech Products Group Corp (KWBT) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
3200 GUASTI ROAD, ONTARIO, CA 91761 |
| State of Incorp. | NV |
| Fiscal Year End | December 31 |
| Industry (SIC) | 287 - Agricultural Chemicals (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
| 12/31/2019 Q4 | 9/30/2019 Q3 | 6/30/2019 Q2 | 3/31/2019 Q1 | 12/31/2018 Q4 | 9/30/2018 Q3 | 6/30/2018 Q2 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 2,021 | 10 | 357 | 8 | 11 | 5,082 | |||
| Cash and cash equivalent | 2,021 | 10 | 357 | 8 | 11 | 5,082 | |||
| Receivables | 3,514 | 3,541 | 7,142 | 6,763 | 6,777 | 7,017 | |||
| Inventory, net of allowances, customer advances and progress billings | 141 | 115 | 117 | 1,643 | 1,645 | 1,706 | |||
| Inventory | 141 | 115 | 117 | 1,643 | 1,645 | 1,706 | |||
| Prepaid expense | 1,434 | 1,840 | 1,909 | 2,260 | 2,858 | 3,118 | |||
| Deferred costs | 2,427 | 2,518 | 5,051 | 4,930 | 4,924 | 5,109 | |||
| Other undisclosed current assets | 22,782 | 23,374 | 20,458 | 16,087 | 13,693 | 6,553 | |||
| Total current assets: | 32,320 | 31,398 | 35,034 | 31,690 | 29,909 | 28,585 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 54 | ✕ | ✕ | ✕ | |||||
| Property, plant and equipment | 70 | 118 | 90 | 93 | 55 | 64 | |||
| Long-term investments and receivables | 702 | 728 | 745 | 727 | 728 | 755 | |||
| Long-term investments | 702 | 728 | 745 | 727 | 728 | 755 | |||
| Deposits noncurrent assets | 1 | 1 | 74 | ||||||
| Deferred income tax assets | ✕ | ✕ | ✕ | ||||||
| Total noncurrent assets: | 825 | 846 | 835 | 821 | 784 | 893 | |||
| TOTAL ASSETS: | 33,145 | 32,244 | 35,869 | 32,511 | 30,693 | 29,478 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 10,199 | 10,140 | 8,804 | 7,604 | 6,303 | 5,191 | |||
| Interest and dividends payable | 2,270 | 2,158 | 2,051 | 2,021 | 1,935 | 1,856 | |||
| Taxes payable | 4,277 | 4,171 | 3,546 | 2,947 | 2,402 | 1,968 | |||
| Employee-related liabilities | 1,391 | 1,260 | 1,126 | 1,025 | 738 | 487 | |||
| Accounts payable | 2,261 | 2,551 | 2,081 | 1,611 | 1,229 | 880 | |||
| Deferred revenue | 3,252 | 3,373 | 6,917 | ✕ | ✕ | ✕ | |||
| Debt | 159 | 138 | 138 | 360 | 360 | 360 | |||
| Derivative instruments and hedges, liabilities | 20 | 69 | 1 | 7 | 3 | 46 | |||
| Other liabilities | 2,803 | 2,840 | 2,824 | 2,940 | 2,822 | 2,846 | |||
| Due to related parties | 275 | 291 | 261 | 571 | 553 | 528 | |||
| Contract with customer, liability | ✕ | ✕ | ✕ | ✕ | 6,751 | ||||
| Other undisclosed current liabilities | 2,818 | 2,289 | 1,676 | 1,552 | 8,145 | 7,850 | |||
| Total current liabilities: | 19,525 | 19,141 | 20,621 | 19,785 | 18,188 | 16,820 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 33 | 587 | |||||||
| Long-term debt, excluding current maturities | 587 | ||||||||
| Operating lease, liability | 33 | ✕ | ✕ | ✕ | |||||
| Total noncurrent liabilities: | 33 | 587 | |||||||
| Total liabilities: | 19,558 | 19,141 | 20,621 | 19,785 | 18,188 | 17,408 | |||
| Equity | |||||||||
| Equity, attributable to parent, including: | 13,587 | 13,103 | 15,248 | 12,727 | 12,505 | 12,071 | |||
| Preferred stock | 1 | 1 | |||||||
| Common stock | 20 | 19 | 19 | 17 | 17 | 17 | |||
| Common stock, share subscribed but unissued, subscriptions receivable | (1,023) | (1,023) | (1,023) | (1,023) | (458) | (458) | |||
| Additional paid in capital | 30,119 | 29,283 | 28,764 | 27,047 | 27,098 | 26,718 | |||
| Accumulated other comprehensive income (loss) | (1,229) | (565) | (146) | (558) | (527) | 42 | |||
| Accumulated deficit | (16,347) | (16,659) | (14,413) | (14,804) | (14,542) | (15,165) | |||
| Other undisclosed equity, attributable to parent | 2,045 | 2,045 | 2,047 | 2,047 | 918 | 918 | |||
| Total equity: | 13,587 | 13,103 | 15,248 | 12,727 | 12,505 | 12,071 | |||
| TOTAL LIABILITIES AND EQUITY: | 33,145 | 32,244 | 35,869 | 32,511 | 30,693 | 29,478 | |||
Income Statement (P&L) ($ in thousands)Annual | Quarterly
| 12/31/2019 Q4 | 9/30/2019 Q3 | 6/30/2019 Q2 | 3/31/2019 Q1 | 12/31/2018 Q4 | 9/30/2018 Q3 | 6/30/2018 Q2 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 10,986 | 10,925 | 9,543 | 8,839 | 7,726 | 5,335 | ||
| Cost of revenue (Cost of Product and Service Sold) | (8,409) | (7,753) | (7,367) | (6,760) | (5,452) | (3,874) | ||
| Gross profit: | 2,577 | 3,172 | 2,176 | 2,079 | 2,273 | 1,461 | ||
| Operating expenses | (725) | (3,915) | (997) | (1,104) | (1,062) | (1,715) | ||
| Operating income (loss): | 1,853 | (743) | 1,179 | 975 | 1,211 | (253) | ||
| Nonoperating expense | (1,290) | (789) | (267) | (178) | (73) | (24) | ||
| Gain (loss), foreign currency transaction, before tax | 35 | 22 | (23) | 1 | 36 | 56 | ||
| Other nonoperating income (expense) | (1) | (3) | 55 | |||||
| Interest and debt expense | (1,372) | (836) | (30) | (175) | (152) | (153) | ||
| Other undisclosed income from continuing operations before equity method investments, income taxes | 1,372 | 836 | 30 | 175 | 152 | 153 | ||
| Income (loss) from continuing operations before income taxes: | 563 | (1,532) | 912 | 797 | 1,138 | (277) | ||
| Income tax expense (benefit) | 252 | (714) | 521 | 495 | 514 | 358 | ||
| Other undisclosed loss from continuing operations | (989) | (1,029) | (716) | |||||
| Income (loss) from continuing operations: | 815 | (2,246) | 1,432 | 303 | 623 | (635) | ||
| Income (loss) before gain (loss) on sale of properties: | 815 | (2,246) | 1,432 | 303 | 623 | (635) | ||
| Net income (loss): | 815 | (2,246) | 1,432 | 303 | 623 | (635) | ||
| Other undisclosed net loss attributable to parent | (504) | (1,042) | ||||||
| Net income (loss) available to common stockholders, diluted: | 311 | (2,246) | 391 | 303 | 623 | (635) | ||
Comprehensive Income ($ in thousands)Annual | Quarterly
| 12/31/2019 Q4 | 9/30/2019 Q3 | 6/30/2019 Q2 | 3/31/2019 Q1 | 12/31/2018 Q4 | 9/30/2018 Q3 | 6/30/2018 Q2 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | 815 | (2,246) | 1,432 | 303 | 623 | (635) | ||
| Other comprehensive income (loss) | (664) | (419) | 412 | |||||
| Other undisclosed comprehensive loss | (882) | |||||||
| Comprehensive income (loss): | 151 | (2,664) | 1,845 | (579) | 623 | (635) | ||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | (504) | (1,042) | 851 | (570) | (781) | |||
| Comprehensive income (loss), net of tax, attributable to parent: | (353) | (2,664) | 803 | 272 | 54 | (1,416) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.